index
Bookmark and Share




Newsletter



Team Up! Against Cancer puts cancer surviors together with cancer patients and their families, in the church and in the community.



Get current and comprehensive information about specific types of cancer, updates on cancer treatments and news about research advances.



CaringBridge is a nonprofit organization offering free, personalized websites that allow people to stay in touch with family and friends during a health crisis, treatment and recovery.




Brought to you by:
CancerMonthly.com
and
SurvivingMesothelioma.com


Palladium Lipoic Complexes (Poly-MVA)
in the Fight against Cancer

 

Existing conventional cancer therapies focus on the use of exceedingly toxic therapies in the attempt to kill off as many cancerous cells as possible. The collateral damage seen with these methods is substantial. Chemotherapy, radiation and surgery are effective but infamously unsafe and may cause serious debility, have long-term side effects, cause other forms of cancer or even result in death. Because significant numbers of patients who undergo these treatments end up dying, it is not truly possible to know how many of their deaths were very much attributable to these toxic treatment regimens. In how many cases are the treatments worse than the disease?

The key to success in the war on cancer is to fight it intelligently, with the best tools available. Complementary/alternative medicine (CAM) cancer treatments can be seen as clear alternatives to allopathic methodologies as well as an adjuvant approach to be used in conjunction with more mainstream methods. The ideal treatment for cancer would discerningly target cancerous cells, while at the same time shielding and strengthening healthy cells. Palladium Lipoic Complexes (a newly-recognized class of nutritional supplements), may well help accomplish this objective by becoming the centerpiece in integrative and non-toxic cancer therapy.

Poly-MVA, a member of the family of compounds known as Palladium Lipoic Lipoic Complexes, is a uniquely-formulated dietary supplement containing a proprietary blend of the mineral palladium bonded to alpha-lipoic acid, Vitamins B1, B2 and B12, formyl-methionine, N-acetyl cysteine, plus trace amounts of molybdenum, rhodium, and ruthenium. This formulation is designed to provide energy for compromised body systems, such as those undergoing chemotherapy or radiation treatment. Poly-MVA can assist in boosting immune response, replenishing key nutrients and supporting cellular metabolism. The proprietary formulation of lipoic acid with other vitamins, minerals, and amino acids provides considerable nutritional support, helping to enable optimum functioning of essential body systems. While it's most significant use is in the fight against cancer, Poly-MVA's lack of toxicity, as well as its many revitalizing and healing effects on cell function, make it a superlative cellular nutrient for prevention of other degenerative diseases and support of optimal health and quality of life.

The Foundation for Advancement in Cancer Research places value in Poly-MVA as a product that can assist those people who suffer from various forms and stages of cancer. Compelling evidence indicates that it can support the body to target and eradicate cancerous cells without damaging healthy ones.

The recent and continuing research on Poly-MVA and what it can accomplish with cancer and other diseases is solid and has been well-received. Click here to read more about these exciting results.

In addition, an ongoing Quality of Life Study is being conducted by the Foundation in conjunction with AMARC Enterprises, the primary distributor for Poly-MVA. The study's objective is to gather crucial quality of life information, observing parameters such as energy, mood, efficacy and memory retention in relation to the consumption of the supplement. To read more about this study, or to sign up, click here.

To learn more about Palladium Lipoic Complexes and Poly-MVA, click here.